Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.36p
   
  • Change Today:
    -0.44p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 4,073,271
  • Market Cap: £31.97m
  • RiskGrade: 328
  • Beta: 0.87

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £94,666
Lisa Baderoon 583,963 £37,140
Tim Franklin 525,000 £33,390

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,596,872
Invesco Ltd 17,872,341 £1,136,681
Aviva Investors Global 11,285,180 £717,737
Alora Pharmaceuticals LLC 10,909,091 £693,818
M&G Investments 7,600,000 £483,360
Prudential plc 7,600,000 £483,360
Capital Income Builder 4,870,367 £309,755
Dr R Zimmer 4,551,553 £289,479
Odey Asset Management 3,433,319 £218,359
Rhone Trustees (Switzerland) SA 3,386,000 £215,350
Pictet Overseas Trust Corporation Limited 3,287,500 £209,085

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.36p
Change Today -0.44p
% Change -6.47 %
52 Week High 17.60
52 Week Low 1.50
Volume 4,073,271
Shares Issued 502.72m
Market Cap £31.97m
Beta 0.87
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 30-Jan-2026

Time Volume / Share Price
15:03 234,558 @ 6.40p
15:44 120,000 @ 6.33p
16:26 50,000 @ 6.33p
16:22 77,167 @ 6.46p
16:10 9,164 @ 6.46p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page